Back to Search
JE JUNG UHM, PHARMD
PHARMD
Pharmacist
NPI: 1689021149Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
051290215(IL)
Research & Publications (20)
Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
PMID 17382252·Biol Blood Marrow Transplant·2007
8-other
Isolation and characterization of NgRLK1, a receptor-like kinase of Nicotiana glutinosa that interacts with the elicitin of Phytophthora capsici.
PMID 19449126·Mol Biol Rep·2010
8-other
A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma.
PMID 19557631·Leuk Lymphoma·2009
8-other
Clinical Reasoning: a 52-year-old man with spells of altered consciousness and severe headaches.
PMID 19470959·Neurology·2009
5-case
A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.
PMID 19358705·BMC Cancer·2009
8-other
Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer.
PMID 19221753·Cancer Chemother Pharmacol·2009
3-trial
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.
PMID 19066894·Cancer Chemother Pharmacol·2009
3-trial
Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.
PMID 19065658·Int J Cancer·2009
8-other
The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
PMID 18989796·Med Oncol·2009
8-other
Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract.
PMID 18988001·Med Oncol·2009
8-other
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.
PMID 18839175·Cancer Chemother Pharmacol·2009
3-trial
A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma.
PMID 18726098·Cancer Chemother Pharmacol·2009
3-trial
Clinical features and prognostic factors of patients with "peripheral T cell lymphoma, unspecified".
PMID 18648812·Ann Hematol·2009
8-other
Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?
PMID 18553084·Cancer Chemother Pharmacol·2009
8-other
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
PMID 19609538·Int J Colorectal Dis·2009
3-trial
PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel.
PMID 18559622·Clin Cancer Res·2008
7-preclinical
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
PMID 18955445·J Clin Oncol·2008
3-trial
What is stage II in high-grade primary gastric lymphoma? How to define the range of "localized disease".
PMID 17027954·Leuk Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5516 N CLARK ST
CHICAGO, IL 60640 - Phone
- (773) 784-7348
Quick Facts
- NPI
- 1689021149
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile